60
Participants
Start Date
May 18, 2017
Primary Completion Date
August 13, 2018
Study Completion Date
August 13, 2018
Verinurad 9 mg+Febuxostat 80 mg
Capsule administered orally, once daily for 24 weeks
Placebo
Capsule administered orally, once daily for 24 weeks
Research Site, Houston
Research Site, Houston
Research Site, Sugar Land
Research Site, Pearland
Research Site, Webster
Research Site, Los Angeles
Research Site, Los Angeles
Research Site, Los Angeles
Research Site, Lakewood
Research Site, Canyon Country
Research Site, North Hollywood
Research Site, Chula Vista
Research Site, Escondido
Research Site, Orange
Research Site, Corona
Research Site, Lincoln
Research Site, Sacramento
Research Site, Oceanside
Lead Sponsor
AstraZeneca
INDUSTRY